Canada markets closed

Myriad Genetics, Inc. (MYGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.18+0.20 (+1.11%)
At close: 04:00PM EDT
18.18 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-06-30
Total Revenue
753,200
753,200
678,400
690,600
638,600
Cost of Revenue
236,200
236,200
202,000
197,600
186,100
Gross Profit
517,000
517,000
476,400
493,000
452,500
Operating Expenses
Research Development
88,700
88,700
85,400
81,900
77,200
Selling General and Administrative
572,900
572,900
514,700
537,800
507,300
Total Operating Expenses
661,600
661,600
600,100
619,700
584,500
Operating Income or Loss
-144,600
-144,600
-123,700
-126,700
-132,000
Interest Expense
2,900
2,900
3,200
6,600
10,800
Total Other Income/Expenses Net
-117,200
-117,200
-16,300
75,500
-83,500
Income Before Tax
-262,200
-262,200
-140,600
-57,100
-223,300
Income Tax Expense
1,100
1,100
-28,600
-29,900
-23,700
Income from Continuing Operations
-263,300
-263,300
-112,000
-27,200
-199,600
Net Income
-263,300
-263,300
-112,000
-27,200
-199,500
Net Income available to common shareholders
-263,300
-263,300
-112,000
-27,200
-199,500
Basic EPS
-3.09
-3.18
-1.39
-0.35
-2.69
Diluted EPS
-3.09
-3.18
-1.39
-0.35
-2.69
Basic Average Shares
74,750
82,800
80,600
78,000
74,300
Diluted Average Shares
74,750
82,800
80,600
78,000
74,300